Bayer's mineralocorticoid receptor antagonist (MRA) Kerendia hit the mark as a treatment for a common form of heart failure in the FINEARTS-HF study, setting up regulatory approvals, but there is ...
On the heels of approvals in the US, Europe and Japan, Bayer's Kerendia for chronic kidney disease (CKD) associated with type 2 diabetes has been cleared for use in China, unlocking another big ...
Kerendia sales surged 96.4%, mainly due to a substantial rise in volumes in the United States and business expansion in China. However, sales of oral anticoagulant Xarelto, co-developed with J&J ...
The thinking was that the drug could be a possible rival to Bayer’s approved chronic kidney disease (CKD) drug Kerendia. But those ambitions went up in flames in July when a prespecified interim ...
From the decorations and lights to the nostalgic scents, there truly is no time like the holidays! Homes across the world transform into more beautiful versions of themselves in anticipation of ...